Logo image of SYM

SYMBOTIC INC (SYM) Stock Fundamental Analysis

NASDAQ:SYM - Nasdaq - US87151X1019 - Common Stock - Currency: USD

24.47  -1.62 (-6.21%)

After market: 24.78 +0.31 (+1.27%)

Fundamental Rating

4

SYM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 129 industry peers in the Machinery industry. The financial health of SYM is average, but there are quite some concerns on its profitability. SYM shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SYM had negative earnings in the past year.
SYM had a positive operating cash flow in the past year.
In the past 5 years SYM always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: SYM reported negative operating cash flow in multiple years.
SYM Yearly Net Income VS EBIT VS OCF VS FCFSYM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

With a Return On Assets value of -0.88%, SYM is not doing good in the industry: 68.80% of the companies in the same industry are doing better.
The Return On Equity of SYM (-7.65%) is worse than 69.60% of its industry peers.
Industry RankSector Rank
ROA -0.88%
ROE -7.65%
ROIC N/A
ROA(3y)-1.41%
ROA(5y)-24.27%
ROE(3y)-9735.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SYM Yearly ROA, ROE, ROICSYM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

1.3 Margins

SYM has a Gross Margin of 13.41%. This is amonst the worse of the industry: SYM underperforms 86.40% of its industry peers.
SYM's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for SYM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.29%
GM growth 5YN/A
SYM Yearly Profit, Operating, Gross MarginsSYM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

6

2. Health

2.1 Basic Checks

SYM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SYM has more shares outstanding
SYM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SYM Yearly Shares OutstandingSYM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SYM Yearly Total Debt VS Total AssetsSYM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

SYM has an Altman-Z score of 5.66. This indicates that SYM is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.66, SYM is in the better half of the industry, outperforming 79.20% of the companies in the same industry.
SYM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.66
ROIC/WACCN/A
WACC10.6%
SYM Yearly LT Debt VS Equity VS FCFSYM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

2.3 Liquidity

SYM has a Current Ratio of 1.22. This is a normal value and indicates that SYM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.22, SYM is doing worse than 87.20% of the companies in the same industry.
A Quick Ratio of 1.13 indicates that SYM should not have too much problems paying its short term obligations.
SYM has a Quick ratio (1.13) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.13
SYM Yearly Current Assets VS Current LiabilitesSYM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

7

3. Growth

3.1 Past

SYM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.48%, which is quite impressive.
The Revenue has grown by 42.37% in the past year. This is a very strong growth!
Measured over the past years, SYM shows a very strong growth in Revenue. The Revenue has been growing by 77.99% on average per year.
EPS 1Y (TTM)91.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)42.37%
Revenue growth 3Y92.19%
Revenue growth 5Y77.99%
Sales Q2Q%32.09%

3.2 Future

The Earnings Per Share is expected to grow by 147.85% on average over the next years. This is a very strong growth
SYM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.47% yearly.
EPS Next Y760.38%
EPS Next 2Y303.18%
EPS Next 3Y178.83%
EPS Next 5Y147.85%
Revenue Next Year29.55%
Revenue Next 2Y30.58%
Revenue Next 3Y27.25%
Revenue Next 5Y26.47%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SYM Yearly Revenue VS EstimatesSYM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
SYM Yearly EPS VS EstimatesSYM Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SYM. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 44.01, SYM can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SYM indicates a slightly more expensive valuation: SYM is more expensive than 67.20% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of SYM to the average of the S&P500 Index (22.68), we can say SYM is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 44.01
SYM Price Earnings VS Forward Price EarningsSYM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600 -800 -1K

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of SYM indicates a slightly more expensive valuation: SYM is more expensive than 67.20% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 111.03
EV/EBITDA N/A
SYM Per share dataSYM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

SYM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SYM's earnings are expected to grow with 178.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y303.18%
EPS Next 3Y178.83%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SYM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SYMBOTIC INC

NASDAQ:SYM (2/21/2025, 8:00:01 PM)

After market: 24.78 +0.31 (+1.27%)

24.47

-1.62 (-6.21%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)05-05 2025-05-05/bmo
Inst Owners82.88%
Inst Owner Change-78.47%
Ins Owners0.42%
Ins Owner Change0.07%
Market Cap14.40B
Analysts75.65
Price Target34.94 (42.79%)
Short Float %18.88%
Short Ratio6.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-56.82%
Min EPS beat(2)-114.67%
Max EPS beat(2)1.03%
EPS beat(4)1
Avg EPS beat(4)-75.98%
Min EPS beat(4)-157.01%
Max EPS beat(4)1.03%
EPS beat(8)3
Avg EPS beat(8)-58.4%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)9.79%
Min Revenue beat(2)-1.85%
Max Revenue beat(2)21.43%
Revenue beat(4)3
Avg Revenue beat(4)6.54%
Min Revenue beat(4)-1.85%
Max Revenue beat(4)21.43%
Revenue beat(8)6
Avg Revenue beat(8)10.91%
Revenue beat(12)9
Avg Revenue beat(12)16.25%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.13%
PT rev (3m)-14.5%
EPS NQ rev (1m)-24.21%
EPS NQ rev (3m)-45.21%
EPS NY rev (1m)-10.53%
EPS NY rev (3m)-29.17%
Revenue NQ rev (1m)-5.1%
Revenue NQ rev (3m)-9.64%
Revenue NY rev (1m)-1.08%
Revenue NY rev (3m)-3.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 44.01
P/S 7.55
P/FCF 111.03
P/OCF 81.3
P/B 73.26
P/tB 79.29
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)0.56
Fwd EY2.27%
FCF(TTM)0.22
FCFY0.9%
OCF(TTM)0.3
OCFY1.23%
SpS3.24
BVpS0.33
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.88%
ROE -7.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.41%
FCFM 6.8%
ROA(3y)-1.41%
ROA(5y)-24.27%
ROE(3y)-9735.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.29%
GM growth 5YN/A
F-Score6
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 169.8%
Cap/Sales 2.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 1.13
Altman-Z 5.66
F-Score6
WACC10.6%
ROIC/WACCN/A
Cap/Depr(3y)206.19%
Cap/Depr(5y)195.83%
Cap/Sales(3y)2.24%
Cap/Sales(5y)3.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y760.38%
EPS Next 2Y303.18%
EPS Next 3Y178.83%
EPS Next 5Y147.85%
Revenue 1Y (TTM)42.37%
Revenue growth 3Y92.19%
Revenue growth 5Y77.99%
Sales Q2Q%32.09%
Revenue Next Year29.55%
Revenue Next 2Y30.58%
Revenue Next 3Y27.25%
Revenue Next 5Y26.47%
EBIT growth 1Y29.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year286.7%
EBIT Next 3Y104.08%
EBIT Next 5Y83.91%
FCF growth 1Y223.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y303.33%
OCF growth 3YN/A
OCF growth 5YN/A